{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T06:22:39Z","timestamp":1791958959747,"version":"4.3.4"},"update-to":[{"DOI":"10.1002\/14651858.cd001833.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,6,23]],"date-time":"2014-06-23T00:00:00Z","timestamp":1403481600000}}],"reference-count":296,"publisher":"Wiley","issue":"6","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd001833.pub3","type":"journal-article","created":{"date-parts":[[2014,6,23]],"date-time":"2014-06-23T12:17:13Z","timestamp":1403525833000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults"],"prefix":"10.1002","volume":"2014","author":[{"given":"Kristine","family":"Macartney","sequence":"first","affiliation":[{"name":"Children's Hospital at Westmead and University of Sydney; National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases; Locked Bag 4001 Westmead Sydney NSW Australia 2145"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Heywood","sequence":"additional","affiliation":[{"name":"University of New South Wales; School of Public Health and Community Medicine; Level 2, Samuels Building Gate 11, Botany Street Kensington NSW Australia 2052"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"McIntyre","sequence":"additional","affiliation":[{"name":"Children's Hospital at Westmead and University of Sydney; National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases; Locked Bag 4001 Westmead Sydney NSW Australia 2145"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,6,23]]},"reference":[{"issue":"Suppl","key":"10.1002\/14651858.CD001833.pub3-BIB0001|cit1","first-page":"748","article-title":"Varicella vaccine studies in healthy children and adults","volume":"78","author":"Arbeter","year":"1986","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0002|cit2","first-page":"3","article-title":"Protection against varicella in family contacts by immediate inoculation with live varicella vaccine","volume":"59","author":"Asano","year":"1977","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.vaccine.2004.06.004","article-title":"Efficacy of postexposure immunization with live attenuated varicella vaccine in the household setting - a pilot study","volume":"23","author":"Mor","year":"2004","journal-title":"Vaccine"},{"issue":"7","key":"10.1002\/14651858.CD001833.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"A364","DOI":"10.1016\/j.jval.2013.08.239","article-title":"Considering economic analyses in the revision of the preventive vaccination law: a new direction for health policy-making in Japan?","volume":"16","author":"Akazawa","year":"2013","journal-title":"Value in Health"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00467-001-0789-7","article-title":"Varicella vaccination in children with steroid-sensitive nephrotic syndrome","volume":"17","author":"Alpay","year":"2002","journal-title":"Pediatric Nephrology"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1086\/338959","article-title":"Persistence of immunity to live attenuated varicella vaccine in healthy adults","volume":"34","author":"Ampofo","year":"2002","journal-title":"Clinical Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD001833.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1517\/14728214.2011.591786","article-title":"Emerging drugs for varicella-zoster virus infections","volume":"16","author":"Andrei","year":"2011","journal-title":"Expert Opinion of Emerging Drugs"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0022-3476(82)80506-4","article-title":"Live attenuated varicella vaccine: immunization of healthy children with the OKA strain","volume":"100","author":"Arbeter","year":"1982","journal-title":"Journal of Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD001833.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1542\/peds.71.3.307","article-title":"Live attenuated varicella vaccine: the KMcC strain in healthy children","volume":"71","author":"Arbeter","year":"1983","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1001\/archpedi.1984.02140430012004","article-title":"Varicella vaccine trials in healthy children. A summary of comparative and follow-up studies","volume":"138","author":"Arbeter","year":"1984","journal-title":"American Journal of Diseases of Children"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0011|cit11","first-page":"748","article-title":"Varicella vaccine studies in healthy children and adults","volume":"78","author":"Arbeter","year":"1986","journal-title":"Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD001833.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1542\/peds.85.3.338","article-title":"Immunization of children with acute lymphoblastic leukemia with live attenuated varicella vaccine without complete suspension of chemotherapy","volume":"85","author":"Arbeter","year":"1990","journal-title":"Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD001833.pub3-BIB0013|cit13","first-page":"13","article-title":"Vaccination status among medical students of Universidade do Sul de Santa Catarina before internship","volume":"18","author":"Arent","year":"2009","journal-title":"Revista de Ci\u00eancias M\u00e9dicas"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0014|cit14","first-page":"35","article-title":"Application of a live attenuated varicella vaccine to hospitalized children and its protective effect on spread of varicella infection","volume":"18","author":"Asano","year":"1975","journal-title":"Biken Journal"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1542\/peds.60.6.810","article-title":"Clinical and serologic testing of a live varicella vaccine and two-year follow-up for immunity of the vaccinated children","volume":"60","author":"Asano","year":"1977","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0016|cit16","first-page":"8","article-title":"Protective efficacy of vaccination in children in four episodes of natural varicella and zoster in the ward","volume":"59","author":"Asano","year":"1977","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0017|cit17","first-page":"43","article-title":"Protective effect of immediate inoculation of a live varicella vaccine in household contacts in relation to the viral dose and interval between exposure and vaccination","volume":"25","author":"Asano","year":"1982","journal-title":"Biken Journal"},{"issue":"3","key":"10.1002\/14651858.CD001833.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1542\/peds.72.3.291","article-title":"Five-year follow-up study of recipients of live varicella vaccine using enhanced neutralization and fluorescent antibody membrane antigen assays","volume":"72","author":"Asano","year":"1983","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0019|cit19","first-page":"123","article-title":"Persistence of protective immunity after inoculation with live varicella vaccine (strain Oka)","volume":"27","author":"Asano","year":"1984","journal-title":"Biken Journal"},{"issue":"4","key":"10.1002\/14651858.CD001833.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1542\/peds.75.4.667","article-title":"Long-term protective immunity of recipients of the OKA strain of live varicella vaccine","volume":"75","author":"Asano","year":"1985","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1542\/peds.94.4.524","article-title":"Experience and reason: twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine","volume":"94","author":"Asano","year":"1994","journal-title":"Pediatrics"},{"issue":"50","key":"10.1002\/14651858.CD001833.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"6487","DOI":"10.1016\/j.vaccine.2008.08.004","article-title":"Clinicopathologic understanding and control of varicella-zoster virus infection","volume":"26","author":"Asano","year":"2008","journal-title":"Vaccine"},{"issue":"11","key":"10.1002\/14651858.CD001833.pub3-BIB0023|cit23","first-page":"1336","article-title":"Safety and immunogenicity of gelatin-free freeze-dried live attenuated varicella vaccine","volume":"24","author":"Bai","year":"2011","journal-title":"Chinese Journal of Biologicals"},{"issue":"1","key":"10.1002\/14651858.CD001833.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1590\/S0103-05822008000100004","article-title":"Evaluation of chickenpox susceptibility in children with chronic renal failure","volume":"26","author":"Baldacci","year":"2008","journal-title":"Revista Paulista de Pediatria"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0025|cit25","first-page":"555","article-title":"Study of tolerance and effectiveness of a varicella vaccine in leukemic children","volume":"33","author":"Bancillon","year":"1991","journal-title":"Nouvelle Revue Francaise d'Hematologie"},{"issue":"12","key":"10.1002\/14651858.CD001833.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"847","DOI":"10.4161\/hv.9898","article-title":"Economic evaluation of varicella vaccination in Swiss children and adolescents","volume":"5","author":"Banz","year":"2009","journal-title":"Human Vaccines"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0027|cit27","first-page":"1521","article-title":"Varicella vaccine in children and adolescents with systemic lupus erythematosus (SLE) immunogenicity and safety","volume":"60","author":"Barbosa","year":"2009","journal-title":"Arthritis and Rheumatism"},{"issue":"5","key":"10.1002\/14651858.CD001833.pub3-BIB0028|cit28","first-page":"791","article-title":"Immune response and tolerability of varicella vaccine in children and adolescents with systemic lupus erythematosus previously exposed to varicella-zoster virus","volume":"30","author":"Barbosa","year":"2012","journal-title":"Clinical and Experimental Rheumatology"},{"issue":"9","key":"10.1002\/14651858.CD001833.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/adc.2010.209650","article-title":"PEPtalk: postexposure prophylaxis against varicella in children with cancer","volume":"96","author":"Bate","year":"2011","journal-title":"Archives of Disease in Childhood"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0030|cit30","first-page":"27","article-title":"Varicella vaccination safety in children with allergy","volume":"79","author":"Bednarek","year":"2004","journal-title":"Pediatria Polska"},{"issue":"18","key":"10.1002\/14651858.CD001833.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1097\/QAD.0b013e3280113f29","article-title":"Varicella vaccination in HIV-1-infected children after immune reconstitution","volume":"20","author":"Bekker","year":"2006","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/infdis\/162.5.1049","article-title":"The immunogenicity of the Oka\/Merck varicella vaccine in relation to infectious varicella-zoster virus and relative viral antigen content","volume":"162","author":"Bergen","year":"1990","journal-title":"Journal of Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD001833.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/infdis\/149.4.647","article-title":"Enhancement of varicella-zoster-specific immune responses in the elderly by boosting with varicella vaccine","volume":"149","author":"Berger","year":"1984","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0166-3542(85)80037-1","article-title":"Booster vaccination of healthy adults with VZV antibody but without a VZV-specific cell-mediated immune response","volume":"Suppl 1","author":"Berger","year":"1985","journal-title":"Antiviral Research"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001833.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1086\/514265","article-title":"A dose-response study of a live attenuated varicella-zoster virus (Oka strain) vaccine administered to adults 55 years of age and older","volume":"178","author":"Berger","year":"1998","journal-title":"Journal of Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD001833.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/OGX.0b013e3181d0c358","article-title":"Preconception care","volume":"65","author":"Berghella","year":"2010","journal-title":"Obstetrical & Gynecological Survey"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1542\/peds.92.6.833","article-title":"Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka\/Merck varicella vaccine","volume":"92","author":"Bernstein","year":"1993","journal-title":"Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD001833.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/01.inf.0000207409.92198.6f","article-title":"Immunogenicity and safety of measles-mumps-rubella, varicella and Haemophilus influenzae type b vaccines administered concurrently with a fourth dose of heptavalent pneumococcal conjugate vaccine compared with the vaccines administered without heptavalent pneumococcal conjugate vaccine","volume":"25","author":"Black","year":"2006","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001833.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1086\/522124","article-title":"Lack of association between age at varicella vaccination and risk of breakthrough varicella, within the Northern California Kaiser Permanente Medical Care Program","volume":"197","author":"Black","year":"2008","journal-title":"Journal of Infectious Diseases"},{"issue":"8","key":"10.1002\/14651858.CD001833.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1097\/INF.0b013e318259fc8a","article-title":"Immunogenicity and safety of two tetravalent (measles, mumps, rubella, varicella) vaccines coadministered with hepatitis A and pneumococcal conjugate vaccines to children twelve to fourteen months of age","volume":"31","author":"Blatter","year":"2012","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"2","key":"10.1002\/14651858.CD001833.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/infdis\/146.2.260","article-title":"Antibody response to varicella-zoster virus after natural or vaccine-induced infection","volume":"146","author":"Bogger-Goren","year":"1982","journal-title":"Journal of Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD001833.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/INF.0b013e3181b36022","article-title":"Effectiveness of varicella vaccines as postexposure prophylaxis","volume":"29","author":"Brotons","year":"2010","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD001833.pub3-BIB0043|cit43","first-page":"103","article-title":"Varicella vaccine in children with chronic renal insufficiency","volume":"61","author":"Broyer","year":"1985","journal-title":"Postgraduate Medical Journal"},{"issue":"8307","key":"10.1002\/14651858.CD001833.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0140-6736(82)90006-X","article-title":"Administration of live varicella vaccine to children with leukaemia","volume":"2","author":"Brunell","year":"1982","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD001833.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1542\/peds.77.1.53","article-title":"Risk of herpes zoster in children with leukemia: varicella vaccine compared with history of chickenpox","volume":"77","author":"Brunell","year":"1986","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1542\/peds.81.6.779","article-title":"Combined vaccine against measles, mumps, rubella, and varicella","volume":"81","author":"Brunell","year":"1988","journal-title":"Pediatrics"},{"issue":"8","key":"10.1002\/14651858.CD001833.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.4161\/hv.20357","article-title":"Immunogenicity and safety of measles-mumps-rubella and varicella vaccines coadministered with a fourth dose of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine in toddlers: a pooled analysis of randomized trials","volume":"8","author":"Bryant","year":"2012","journal-title":"Human Vaccines and Immunotherapeutics"},{"issue":"4","key":"10.1002\/14651858.CD001833.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/INF.0b013e318279e9a9","article-title":"Antibody responses to routine pediatric vaccines administered with 13-valent pneumococcal conjugate vaccine","volume":"32","author":"Bryant","year":"2013","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"7-8","key":"10.1002\/14651858.CD001833.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0264-410X(98)00260-6","article-title":"Varicella vaccination of health-care workers","volume":"17","author":"Burgess","year":"1999","journal-title":"Vaccine"},{"issue":"6-7","key":"10.1002\/14651858.CD001833.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/00365540902968027","article-title":"Secondary attack rate of hepatitis A, varicella and mumps in household settings and reliability of family history to detect seronegative children for necessity of vaccination","volume":"41","author":"Ceyhan","year":"2009","journal-title":"Scandinavian Journal of Infectious Diseases"},{"issue":"6","key":"10.1002\/14651858.CD001833.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1017\/S0950268811001786","article-title":"The incidence of varicella and herpes zoster in Taiwan during a period of increasing varicella vaccine coverage, 2000-2008","volume":"140","author":"Chao","year":"2012","journal-title":"Epidemiology and Infection"},{"issue":"15","key":"10.1002\/14651858.CD001833.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.vaccine.2014.01.019","article-title":"Safety and immunogenicity of three different formulations of an adjuvanted varicella-zoster virus subunit candidate vaccine in older adults: a phase II, randomized, controlled study","volume":"32","author":"Chlibek","year":"2014","journal-title":"Vaccine"},{"issue":"1","key":"10.1002\/14651858.CD001833.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/00365548.2013.847529","article-title":"Cost-effectiveness analysis of varicella vaccine as post-exposure prophylaxis in Hong Kong","volume":"46","author":"Chui","year":"2014","journal-title":"Scandinavian Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/00006454-199510000-00011","article-title":"Over five-year follow-up of Oka\/Merck varicella vaccine recipients in 465 infants and adolescents","volume":"14","author":"Clements","year":"1995","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD001833.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1542\/peds.2012-0055J","article-title":"Empirical evaluation of age groups and age-subgroup analyses in pediatric randomized trials and pediatric meta-analyses","volume":"129","author":"Contopoulos-Ioannidis","year":"2012","journal-title":"Pediatrics"},{"issue":"12","key":"10.1002\/14651858.CD001833.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/0264-410X(91)90006-R","article-title":"Administration of live attenuated varicella vaccine to children with cancer before starting chemotherapy","volume":"9","author":"Cristofani","year":"1991","journal-title":"Vaccine"},{"issue":"41","key":"10.1002\/14651858.CD001833.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"6504","DOI":"10.1016\/j.vaccine.2009.07.076","article-title":"A combined measles, mumps, rubella and varicella vaccine (Priorix-Tetra): immunogenicity and safety profile","volume":"27","author":"Czajka","year":"2009","journal-title":"Vaccine"},{"issue":"3","key":"10.1002\/14651858.CD001833.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1542\/peds.2006-2241","article-title":"Measles-mumps-rubella and varicella vaccine responses in extremely preterm infants","volume":"119","author":"D'Angio","year":"2007","journal-title":"Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD001833.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF00277161","article-title":"Characterization and immunogenicity of a candidate subunit vaccine against varicella-zoster virus","volume":"183","author":"Davies","year":"1994","journal-title":"Medical Microbiology & Immunology"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1542\/peds.88.3.604","article-title":"Immunogenicity of subcutaneous versus intramuscular Oka\/Merck varicella vaccination in healthy children","volume":"88","author":"Dennehy","year":"1991","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1542\/peds.94.4.514","article-title":"Seroconversion rates to combined measles-mumps-rubella-varicella vaccine of children with upper respiratory tract infection","volume":"94","author":"Dennehy","year":"1994","journal-title":"Pediatrics"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD001833.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1590\/S0102-311X2009001500006","article-title":"Impact of methodology on the results of economic evaluations of varicella vaccination programs: is it important for decision-making?","volume":"25","author":"So\u00e1rez","year":"2009","journal-title":"Cadernos Saude Publica"},{"issue":"2","key":"10.1002\/14651858.CD001833.pub3-BIB0063|cit63","first-page":"166","article-title":"Lack of transmission of the live attenuated varicella vaccine virus to immunocompromised children after immunization of their siblings","volume":"87","author":"Diaz","year":"1991","journal-title":"Pediatrics"},{"issue":"47-8","key":"10.1002\/14651858.CD001833.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"6875","DOI":"10.1016\/j.vaccine.2006.06.030","article-title":"Safety, tolerability, and immunogenicity of a two-dose regimen of high-titer varicella vaccine in subjects > or = 13 years of age","volume":"24","author":"Diaz","year":"2006","journal-title":"Vaccine"},{"issue":"31","key":"10.1002\/14651858.CD001833.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.1016\/j.vaccine.2012.04.100","article-title":"Clinicians' opinions on new vaccination programs implementation","volume":"30","author":"Dube","year":"2012","journal-title":"Vaccine"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD001833.pub3-BIB0066|cit66","first-page":"147","article-title":"Stimulation of specific immune response to varicella antigens in the elderly with varicella vaccine","volume":"61","author":"Duchateau","year":"1985","journal-title":"Postgraduate Medical Journal"},{"issue":"3","key":"10.1002\/14651858.CD001833.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jaad.2011.07.032","article-title":"Live attenuated varicella vaccine: a new effective adjuvant weapon in the battlefield against severe resistant psoriasis, a pilot randomized controlled trial","volume":"66","author":"El-Darouti","year":"2012","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0022-3476(89)80598-0","article-title":"Placebo-controlled trial of varicella vaccine given with or after measles-mumps-rubella vaccine","volume":"114","author":"Englund","year":"1989","journal-title":"Journal of Pediatrics"},{"issue":"5","key":"10.1002\/14651858.CD001833.pub3-BIB0069|cit69","first-page":"133","article-title":"Varicella outbreak in a residential home; a short report and literature review on postexposure prophylaxis","volume":"99","author":"Enright","year":"2006","journal-title":"Irish Medical Journal"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1586\/14760584.3.3.291","article-title":"Varicella zoster virus: vaccination and implications in children with renal failure","volume":"3","author":"Fadrowski","year":"2004","journal-title":"Expert Review of Vaccines"},{"issue":"7","key":"10.1002\/14651858.CD001833.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"455","DOI":"10.4161\/hv.8269","article-title":"Safety of a refrigerator-stable varicella vaccine (VARIVAX) in healthy 12- to 15-month-old children: a randomized, double-blind, cross-over study","volume":"5","author":"Ferrera","year":"2009","journal-title":"Human Vaccines"},{"issue":"3","key":"10.1002\/14651858.CD001833.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"355","DOI":"10.4161\/hv.18650","article-title":"Booster vaccination of pre-school children with reduced-antigen-content diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine co-administered with measles-mumps-rubella-varicella vaccine: a randomized, controlled trial in children primed according to a 2 + 1 schedule in infancy","volume":"8","author":"Ferrera","year":"2012","journal-title":"Human Vaccines and Immunotherapies"},{"issue":"10","key":"10.1002\/14651858.CD001833.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.4161\/hv.7.10.17816","article-title":"Safety of a second dose of varicella vaccine administered at 4 to 6 years of age in healthy children in Argentina","volume":"7","author":"Fridman","year":"2011","journal-title":"Human Vaccines"},{"issue":"8","key":"10.1002\/14651858.CD001833.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/INF.0b013e3181d7380e","article-title":"The effectiveness of varicella vaccine in China","volume":"29","author":"Fu","year":"2010","journal-title":"Pediatric Infectious Disease Journal"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00467-002-1006-z","article-title":"Varicella vaccination in children with chronic renal failure. A report of the Southwest Pediatric Nephrology Study Group","volume":"18","author":"Furth","year":"2003","journal-title":"Pediatric Nephrology"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1067\/mpd.2003.37","article-title":"Varicella vaccination in children with nephrotic syndrome: a report of the Southwest Pediatric Nephrology Study Group","volume":"142","author":"Furth","year":"2003","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0077|cit77","first-page":"589","article-title":"Immunogenicity and safety of a varicella vaccine, Okavax, and a trivalent measles, mumps and rubella vaccine, MMR-II, administered concomitantly in healthy Filipino children aged 12-24 months","volume":"34","author":"Gatchalian","year":"2003","journal-title":"Southeast Asian Journal of Tropical Medicine & Public Health"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4269\/ajtmh.2004.70.273","article-title":"Immunogenicity and safety of a varicella vaccine (Okavax) and a trivalent measles, mumps, and rubella vaccine (Trimovax) administered concomitantly in healthy Filipino children 12-24 months old","volume":"70","author":"Gatchalian","year":"2004","journal-title":"American Journal of Tropical Medicine & Hygiene"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0079|cit79","first-page":"391","article-title":"Clinical trial of live attenuated varicella vaccine in high risk susceptibles--a preliminary report","volume":"52","author":"Gershon","year":"1982","journal-title":"Developments in Biological Standardization"},{"issue":"3","key":"10.1002\/14651858.CD001833.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1001\/jama.1984.03350030023016","article-title":"Live attenuated varicella vaccine. Efficacy for children with leukemia in remission","volume":"252","author":"Gershon","year":"1984","journal-title":"JAMA"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD001833.pub3-BIB0081|cit81","first-page":"73","article-title":"A multicentre trial of live attenuated varicella vaccine in children with leukaemia in remission","volume":"61","author":"Gershon","year":"1985","journal-title":"Postgraduate Medical Journal"},{"issue":"4 Pt 2","key":"10.1002\/14651858.CD001833.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1542\/peds.78.4.757","article-title":"Live attenuated varicella vaccine use in immunocompromised children and adults","volume":"78","author":"Gershon","year":"1986","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/infdis\/158.1.132","article-title":"Immunization of healthy adults with live attenuated varicella vaccine [Erratum appears in J Infect Dis 1988 Nov;158(5):1149]","volume":"158","author":"Gershon","year":"1988","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1056\/NEJM198904063201403","article-title":"Persistence of immunity to varicella in children with leukemia immunized with live attenuated varicella vaccine","volume":"320","author":"Gershon","year":"1989","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/infdis\/161.4.661","article-title":"Live attenuated varicella vaccine: protection in healthy adults compared with leukemic children. National Institute of Allergy and Infectious Diseases Varicella Vaccine Collaborative Study Group","volume":"161","author":"Gershon","year":"1990","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3109\/00365548.2010.511259","article-title":"Chickenpox in a Swiss prison: susceptibility, post-exposure vaccination and control measures","volume":"42","author":"Getaz","year":"2010","journal-title":"Scandinavian Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0087|cit87","first-page":"1055","article-title":"Varicella vaccine in children requiring renal or hepatic transplantation","volume":"60","author":"Giacchino","year":"1995","journal-title":"Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD001833.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1128\/CVI.00310-07","article-title":"A double-blind, randomized, controlled, multicenter safety and immunogenicity study of a refrigerator-stable formulation of Zostavax","volume":"15","author":"Gilderman","year":"2008","journal-title":"Clinical and Vaccine Immunology"},{"issue":"3","key":"10.1002\/14651858.CD001833.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.vaccine.2008.10.064","article-title":"Immunogenicity and safety of measles-mumps-rubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months-2 years or 2-6 years primed with measles-mumps-rubella (MMR) vaccine","volume":"27","author":"Gillett","year":"2009","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1741-7015-7-16","article-title":"Immunogenicity and safety of concomitant administration of a measles, mumps and rubella vaccine (M-M-RvaxPro) and a varicella vaccine (VARIVAX) by intramuscular or subcutaneous routes at separate injection sites: a randomised clinical trial","volume":"7","author":"Gillet","year":"2009","journal-title":"BMC Medicine"},{"issue":"1","key":"10.1002\/14651858.CD001833.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/archpediatrics.2009.244","article-title":"Parental refusal of varicella vaccination and the associated risk of varicella infection in children","volume":"164","author":"Glanz","year":"2010","journal-title":"Archives of Pediatrics and Adolescent Medicine"},{"issue":"1 Suppl 1","key":"10.1002\/14651858.CD001833.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.jpain.2007.10.007","article-title":"Vaccination to prevent herpes zoster in older adults","volume":"9","author":"Gnann","year":"2008","journal-title":"Journal of Pain"},{"issue":"6","key":"10.1002\/14651858.CD001833.pub3-BIB0093|cit93","first-page":"11","article-title":"Contact with infectious diseases","volume":"94","author":"Gonzaga","year":"2008","journal-title":"Jornal Brasileiro de Medicina"},{"issue":"3","key":"10.1002\/14651858.CD001833.pub3-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jcv.2010.03.003","article-title":"A case of nosocomial VZV transmission","volume":"48","author":"Groves","year":"2010","journal-title":"Journal of Clinical Virology"},{"issue":"10","key":"10.1002\/14651858.CD001833.pub3-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1097\/01.inf.0000238135.01287.b9","article-title":"Safety, tolerability and immunogenicity of VAQTA given concomitantly versus nonconcomitantly with other pediatric vaccines in healthy 12-month-old children","volume":"25","author":"Guerra","year":"2006","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"2","key":"10.1002\/14651858.CD001833.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1542\/peds.65.2.346","article-title":"Application of live varicella vaccine to children with acute leukemia or other malignancies without suspension of anticancer therapy","volume":"65","author":"Ha","year":"1980","journal-title":"Pediatrics"},{"issue":"7-8","key":"10.1002\/14651858.CD001833.pub3-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0264-410X(98)00249-7","article-title":"Cellular immune response of a varicella vaccine following simultaneous DTaP and VZV vaccination","volume":"17","author":"Habermehl","year":"1999","journal-title":"Vaccine"},{"issue":"20","key":"10.1002\/14651858.CD001833.pub3-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1016\/j.vaccine.2009.02.044","article-title":"Safety and immunogenicity of a measles-mumps-rubella-varicella vaccine given as a second dose in children up to six years of age","volume":"27","author":"Halperin","year":"2009","journal-title":"Vaccine"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001833.pub3-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1086\/522131","article-title":"Risk of herpes zoster in adults immunized with varicella vaccine","volume":"197","author":"Hambleton","year":"2008","journal-title":"Journal of Infectious Disease"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1056\/NEJM199111283252204","article-title":"The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group","volume":"325","author":"Hardy","year":"1991","journal-title":"New England Journal of Medicine"},{"issue":"11","key":"10.1002\/14651858.CD001833.pub3-BIB0101|cit101","first-page":"494","article-title":"Immunity to varicella zoster virus in clinical trials of fingolimod in patients with multiple sclerosis","volume":"19","author":"Hartung","year":"2013","journal-title":"Multiple Sclerosis"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1056\/NEJMoa013441","article-title":"Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants","volume":"347","author":"Hata","year":"2002","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/infdis\/166.2.260","article-title":"Varicella-zoster virus (VZV)-specific cytotoxicity after immunization of nonimmune adults with Oka strain attenuated VZV vaccine","volume":"166","author":"Hayward","year":"1992","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1089\/vim.1994.7.31","article-title":"Immune response to secondary immunization with live or inactivated VZV vaccine in elderly adults","volume":"7","author":"Hayward","year":"1994","journal-title":"Viral Immunology"},{"issue":"4","key":"10.1002\/14651858.CD001833.pub3-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1089\/vim.1996.9.241","article-title":"Varicella zoster virus-specific cytotoxicity following secondary immunization with live or killed vaccine","volume":"9","author":"Hayward","year":"1996","journal-title":"Viral Immunology"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD001833.pub3-BIB0106|cit106","first-page":"79","article-title":"Early results of a trial of the Oka-strain varicella vaccine in children with leukaemia or other malignancies in Sweden","volume":"61","author":"Heller","year":"1985","journal-title":"Postgraduate Medical Journal"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/01.inf.0000114902.84651.02","article-title":"Concomitant administration of a bivalent Haemophilus influenzae type b-hepatitis B vaccine, measles-mumps-rubella vaccine and varicella vaccine: safety, tolerability and immunogenicity","volume":"23","author":"Hesley","year":"2004","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"2","key":"10.1002\/14651858.CD001833.pub3-BIB0108|cit108","first-page":"119","article-title":"A novel vaccine (Zostavax) to prevent herpes zoster","volume":"143","author":"Holcomb","year":"2008","journal-title":"Giornale Italiano di Dermatologia e Venereologia"},{"issue":"2-3","key":"10.1002\/14651858.CD001833.pub3-BIB0109|cit109","first-page":"37","article-title":"Chickenpox vaccination of healthy children: immunological and clinical responses and protective effect in 1978-1982","volume":"27","author":"Horiuchi","year":"1984","journal-title":"Biken Journal"},{"issue":"6","key":"10.1002\/14651858.CD001833.pub3-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.4161\/hv.24035","article-title":"Immunogenicity and safety of combined measles-mumps-rubella-varicella vaccine using new measles and rubella working seeds in healthy children in Taiwan and Singapore: a phase II, randomized, double-blind trial","volume":"9","author":"Huang","year":"2013","journal-title":"Human Vaccines and Immunotherapeutics"},{"issue":"5","key":"10.1002\/14651858.CD001833.pub3-BIB0111|cit111","first-page":"561","article-title":"Reactogenic and immunogenic properties of an attenuated strain of chicken pox virus","volume":"33","author":"Iovlev","year":"1969","journal-title":"Voprosy Neirokhirurgii"},{"issue":"6","key":"10.1002\/14651858.CD001833.pub3-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1542\/peds.60.6.805","article-title":"Application of a live varicella vaccine in children with acute leukemia or other malignant diseases","volume":"60","author":"Izawa","year":"1977","journal-title":"Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD001833.pub3-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1542\/peds.81.4.512","article-title":"Live attenuated varicella vaccine in healthy 12- to 24-month-old children","volume":"81","author":"Johnson","year":"1988","journal-title":"Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD001833.pub3-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1542\/peds.84.3.418","article-title":"Humoral immunity and clinical reinfections following varicella vaccine in healthy children","volume":"84","author":"Johnson","year":"1989","journal-title":"Pediatrics"},{"issue":"52","key":"10.1002\/14651858.CD001833.pub3-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"7398","DOI":"10.1016\/j.vaccine.2009.08.081","article-title":"Tracking epitope-specific antiviral CD4+ T cell responses to a live attenuated vaccine reveals ongoing functional responses","volume":"27","author":"Jones","year":"2009","journal-title":"Vaccine"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD001833.pub3-BIB0116|cit116","first-page":"129","article-title":"Live varicella vaccine in healthy individuals","volume":"61","author":"Just","year":"1985","journal-title":"Postgraduate Medical Journal"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0117|cit117","first-page":"85","article-title":"Evaluation of a combined measles-mumps-rubella-chickenpox vaccine","volume":"65","author":"Just","year":"1986","journal-title":"Developments in Biological Standardization"},{"issue":"6","key":"10.1002\/14651858.CD001833.pub3-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1046\/j.1442-200x.2000.01300.x","article-title":"Safety and immunogenicity of live attenuated varicella vaccine in 9-month-old children","volume":"42","author":"Kanra","year":"2000","journal-title":"Pediatrics International"},{"issue":"1","key":"10.1002\/14651858.CD001833.pub3-BIB0119|cit119","first-page":"29","article-title":"Application of a live varicella vaccine to hospitalized children and its follow-up study","volume":"25","author":"Katsushima","year":"1982","journal-title":"Biken Journal"},{"issue":"2-3","key":"10.1002\/14651858.CD001833.pub3-BIB0120|cit120","first-page":"51","article-title":"Effect and follow-up study on varicella vaccine","volume":"27","author":"Katsushima","year":"1984","journal-title":"Biken Journal"},{"issue":"26","key":"10.1002\/14651858.CD001833.pub3-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1016\/j.vaccine.2012.03.080","article-title":"Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine administered concomitantly with measles, mumps, rubella, varicella vaccine in healthy toddlers","volume":"30","author":"Klein","year":"2012","journal-title":"Vaccine"},{"issue":"3","key":"10.1002\/14651858.CD001833.pub3-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.vaccine.2011.10.065","article-title":"An open-label, randomized, multi-center study of the immunogenicity and safety of DTaP-IPV (Kinrix) co-administered with MMR vaccine with or without varicella vaccine in healthy pre-school age children","volume":"30","author":"Klein","year":"2012","journal-title":"Vaccine"},{"issue":"1","key":"10.1002\/14651858.CD001833.pub3-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/01.inf.0000195626.35239.58","article-title":"Immunogenicity and safety of two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children","volume":"25","author":"Knuf","year":"2006","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"8","key":"10.1002\/14651858.CD001833.pub3-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00431-010-1142-6","article-title":"Safety, immunogenicity and immediate pain of intramuscular versus subcutaneous administration of a measles-mumps-rubella-varicella vaccine to children aged 11-21 months","volume":"169","author":"Knuf","year":"2010","journal-title":"European Journal of Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD001833.pub3-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00431-011-1569-4","article-title":"Antibody persistence for 3 years following two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children","volume":"171","author":"Knuf","year":"2012","journal-title":"European Journal of Pediatrics"},{"issue":"2-3","key":"10.1002\/14651858.CD001833.pub3-BIB0126|cit126","first-page":"73","article-title":"A clinical trial of live attenuated varicella vaccine (Biken) in children with malignant diseases","volume":"27","author":"Konno","year":"1984","journal-title":"Biken Journal"},{"issue":"3","key":"10.1002\/14651858.CD001833.pub3-BIB0127|cit127","first-page":"697","article-title":"Advantage of a two-dose versus one-dose varicella vaccine in healthy non-immune teenagers and young adults","volume":"35","author":"Kosuwon","year":"2004","journal-title":"Southeast Asian Journal of Tropical Medicine & Public Health"},{"issue":"1","key":"10.1002\/14651858.CD001833.pub3-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0264-410X(96)00107-7","article-title":"Comparison of gpELISA and neutralizing antibody responses to Oka\/Merck live varicella vaccine (Varivax) in children and adults","volume":"15","author":"Krah","year":"1997","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0022-3476(95)70106-0","article-title":"Efficacy, immunogenicity, safety, and use of live attenuated chickenpox vaccine","volume":"127","author":"Krause","year":"1995","journal-title":"Journal of Pediatrics"},{"issue":"Suppl","key":"10.1002\/14651858.CD001833.pub3-BIB0130|cit130","first-page":"143","article-title":"Double-blind randomised study on the immunogenicity and reactogenicity of three different selections with two different virus titers each of a newly formulated attenuated varicella vaccine (Oka-phylum) [trans]","volume":"142","author":"Kreth","year":"1994","journal-title":"Monatsschrift fur Kinderheilkunde"},{"issue":"10","key":"10.1002\/14651858.CD001833.pub3-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00431-006-0103-6","article-title":"Safety, reactogenicity, and immunogenicity of live attenuated varicella vaccine in children between 1 and 9 years of age with atopic dermatitis","volume":"165","author":"Kreth","year":"2006","journal-title":"European Journal of Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD001833.pub3-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2165\/0063030-200822060-00005","article-title":"Sixteen years of global experience with the first refrigerator-stable varicella vaccine (Varilrix\u2122)","volume":"22","author":"Kreth","year":"2008","journal-title":"Biodrugs"},{"issue":"3","key":"10.1002\/14651858.CD001833.pub3-BIB0133|cit133","first-page":"135","article-title":"Humoral and cellular immune response to varicella-zoster virus in children inoculated with live attenuated varicella vaccine","volume":"23","author":"Kumagai","year":"1980","journal-title":"Biken Journal"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0264-410X(91)90189-D","article-title":"Oka\/Merck varicella vaccine in healthy children: final report of 2 year efficacy study and 7 year follow up studies","volume":"9","author":"Kuter","year":"1991","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/0264-410X(95)00046-4","article-title":"Safety, tolerability, and immunogenicity of two regimens of Oka\/Merck varicella vaccine (Varivax) in healthy adolescents and adults. Oka\/Merck Varicella Vaccine Study Group","volume":"13","author":"Kuter","year":"1995","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/01.inf.0000109287.97518.67","article-title":"Ten year follow-up of healthy children who received one or two injections of varicella vaccine","volume":"23","author":"Kuter","year":"2004","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"5","key":"10.1002\/14651858.CD001833.pub3-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4161\/hv.2.5.3246","article-title":"Safety and immunogenicity of a combination measles, mumps, rubella and varicella vaccine (ProQuad)","volume":"2","author":"Kuter","year":"2006","journal-title":"Human Vaccines"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1016\/S0264-410X(02)00245-1","article-title":"A comparison of safety, tolerability and immunogenicity of Oka\/Merck varicella vaccine and VARILRIX in healthy children","volume":"20","author":"Lau","year":"2002","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1056\/NEJM198803033180904","article-title":"The risk of zoster after varicella vaccination in children with leukemia","volume":"318","author":"Lawrence","year":"1988","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD001833.pub3-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"e1387","DOI":"10.1542\/peds.2010-2132","article-title":"Immunogenicity and safety of MMRV and PCV-7 administered concomitantly in healthy children","volume":"128","author":"Leonardi","year":"2011","journal-title":"Pediatrics"},{"issue":"8","key":"10.1002\/14651858.CD001833.pub3-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1093\/infdis\/jis497","article-title":"A phase 1\/2 clinical trial evaluating safety and immunogenicity of a varicella zoster glycoprotein e subunit vaccine candidate in young and older adults","volume":"206","author":"Leroux-Roels","year":"2012","journal-title":"Journal of Infectious Disease"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1600-0609.2004.00216.x","article-title":"Immunogenicity of a two-dose regime of varicella vaccine in children with cancers","volume":"72","author":"Leung","year":"2004","journal-title":"European Journal of Haematology"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/infdis\/166.2.253","article-title":"Immune response of elderly individuals to a live attenuated varicella vaccine","volume":"166","author":"Levin","year":"1992","journal-title":"Journal of Infectious Diseases"},{"issue":"25","key":"10.1002\/14651858.CD001833.pub3-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1016\/S0264-410X(99)00552-6","article-title":"Comparison of a live attenuated and an inactivated varicella vaccine to boost the varicella-specific immune response in seropositive people 55 years of age and older","volume":"18","author":"Levin","year":"2000","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1067\/mpd.2001.115972","article-title":"Immunization of HIV-infected children with varicella vaccine","volume":"139","author":"Levin","year":"2001","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1086\/379048","article-title":"Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-hose VZV vaccine","volume":"188","author":"Levin","year":"2003","journal-title":"Journal of Infectious Diseases"},{"issue":"6","key":"10.1002\/14651858.CD001833.pub3-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1086\/528696","article-title":"Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine","volume":"197","author":"Levin","year":"2008","journal-title":"Journal of Infectious Diseases"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001833.pub3-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1086\/522133","article-title":"Varicella vaccination of immunocompromised children","volume":"197","author":"Levin","year":"2008","journal-title":"Journal of Infectious Diseases"},{"issue":"12","key":"10.1002\/14651858.CD001833.pub3-BIB0149|cit149","first-page":"1667","article-title":"Safety of freeze-dried live attenuated varicella vaccine","volume":"25","author":"Li","year":"2012","journal-title":"Chinese Journal of Biologicals"},{"issue":"7","key":"10.1002\/14651858.CD001833.pub3-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/01.inf.0000220209.35074.0b","article-title":"The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody","volume":"25","author":"Lieberman","year":"2006","journal-title":"Pediatric Infectious Disease Journal"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1136\/adc.79.6.478","article-title":"Risk factors for breakthrough varicella in healthy children","volume":"79","author":"Lim","year":"1998","journal-title":"Archives of Disease in Childhood"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0152|cit152","first-page":"683","article-title":"Application of a live varicella vaccine in children with acute leukemia or nephrotic syndrome","volume":"80","author":"Lin","year":"1981","journal-title":"Taiwan i Hsueh Hui Tsa Chih [Journal of the Formosan Medical Association]"},{"issue":"4","key":"10.1002\/14651858.CD001833.pub3-BIB0153|cit153","first-page":"371","article-title":"Seroepidemiology of varicella-zoster virus infection measured by the fluorescent antibody to membrane antigen test","volume":"30","author":"Liu","year":"2009","journal-title":"Chung-Hua Liu Hsing Ping Hsueh Tsa Chih [Chinese Journal of Epidemiology]"},{"issue":"2","key":"10.1002\/14651858.CD001833.pub3-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1542\/peds.2010-0962","article-title":"Varicella-related hospitalizations in the United States, 2000-2006: the 1-dose varicella vaccination era","volume":"127","author":"Lopez","year":"2011","journal-title":"Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD001833.pub3-BIB0155|cit155","first-page":"607","article-title":"Experience of varicella vaccination in acute lymphoplastic leukaemia","volume":"37","author":"Lou","year":"1996","journal-title":"Singapore Medical Journal"},{"issue":"26","key":"10.1002\/14651858.CD001833.pub3-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1016\/j.vaccine.2013.04.004","article-title":"Vaccine coverage of healthcare students in hospitals of the Paris region in 2009: The Studyvax Survey","volume":"31","author":"Loulergue","year":"2013","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0157|cit157","first-page":"38","article-title":"Evaluation of a live attenuated varicella vaccine in 15- to 18-month-old healthy children","volume":"39","author":"Lu","year":"1998","journal-title":"Chung-Hua Min Kuo Hsiao Erh Ko i Hsueh Hui Tsa Chih"},{"issue":"6","key":"10.1002\/14651858.CD001833.pub3-BIB0158|cit158","first-page":"559","article-title":"Effectiveness on post-exposure vaccination of varicella and its influencing factors in elementary schools in Beijing","volume":"30","author":"Ma","year":"2009","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"issue":"3","key":"10.1002\/14651858.CD001833.pub3-BIB0159|cit159","first-page":"193","article-title":"Study on epidemiological effect of the freeze-dried attenuated live varicella vaccine","volume":"15","author":"Ma","year":"2009","journal-title":"Zhongguo Jihua Mianyi"},{"issue":"11","key":"10.1002\/14651858.CD001833.pub3-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/j.vaccine.2006.11.011","article-title":"Safety and immunogenicity of a zoster vaccine in varicella-zoster virus seronegative and low-seropositive healthy adults","volume":"25","author":"Macaladad","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"10.1002\/14651858.CD001833.pub3-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1590\/S1516-31802012000200014","article-title":"Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults","volume":"130","author":"Macartney","year":"2012","journal-title":"Sao Paulo Medical Journal"},{"issue":"3","key":"10.1002\/14651858.CD001833.pub3-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"e744","DOI":"10.1542\/peds.2008-0567","article-title":"Varicella prevention in the United States: a review of successes and challenges","volume":"122","author":"Marin","year":"2008","journal-title":"Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD001833.pub3-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S1576-9887(09)73477-6","article-title":"A systematic review of the economic studies on vaccine against herpes zoster and postherpetic neuralgia in adults","volume":"10","author":"Marquez-Pelaez","year":"2009","journal-title":"Vacunas"},{"issue":"5","key":"10.1002\/14651858.CD001833.pub3-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1440-1754.2009.01494.x","article-title":"Varicella immunisation practice: implications for provision of a recommended, non-funded vaccine","volume":"45","author":"Marshall","year":"2009","journal-title":"Journal of Paediatrics and Child Health"},{"issue":"12","key":"10.1002\/14651858.CD001833.pub3-BIB0165|cit165","first-page":"3327","article-title":"Safety and immunogenicity of inactivated varicella-zoster virus vaccine in adults with autoimmune disease","volume":"65","author":"McAdam","year":"2013","journal-title":"Arthritis and Rheumatism"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD001833.pub3-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/infdis\/174.Supplement_3.S324","article-title":"Immunogenicity and safety of a live attenuated varicella vaccine (Oka\/SB Bio) in healthy children","volume":"174","author":"Meurice","year":"1996","journal-title":"Journal of Infectious Diseases"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD001833.pub3-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1586\/erv.10.32","article-title":"Vaccination: a new option to reduce the burden of herpes zoster","volume":"9","author":"Mick","year":"2010","journal-title":"Expert Review of Vaccines"},{"issue":"25","key":"10.1002\/14651858.CD001833.pub3-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1016\/j.vaccine.2010.04.003","article-title":"Safety, tolerability, and immunogenicity of zoster vaccine in subjects with a history of herpes zoster","volume":"28","author":"Mills","year":"2010","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0188-4409(99)00080-6","article-title":"Live varicella vaccine in both immunocompromised and healthy children","volume":"31","author":"Morales-Castillo","year":"2000","journal-title":"Archives of Medical Research"},{"issue":"9","key":"10.1002\/14651858.CD001833.pub3-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1600-0714.2009.00802.x","article-title":"Varicella zoster virus: review of its management","volume":"38","author":"Mustafa","year":"2009","journal-title":"Journal of Oral Pathology and Medicine"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/infdis\/171.1.13","article-title":"Age-related differences in cell-mediated immunity to varicella-zoster virus among children and adults immunized with live attenuated varicella vaccine","volume":"171","author":"Nader","year":"1995","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0172|cit172","first-page":"59","article-title":"Clinical application of a live varicella vaccine (Oka strain) in a hospital","volume":"27","author":"Naganuma","year":"1984","journal-title":"Biken Journal"},{"issue":"8438","key":"10.1002\/14651858.CD001833.pub3-BIB0173|cit173","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/S0140-6736(85)92443-2","article-title":"Immunisation of nurses with a live varicella vaccine","volume":"1","author":"Ndumbe","year":"1985","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD001833.pub3-BIB0174|cit174","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3181\/00379727-166-41071","article-title":"Clinical and laboratory studies of KMcC strain live attenuated varicella virus","volume":"166","author":"Neff","year":"1981","journal-title":"Proceedings of the Society for Experimental Biology & Medicine"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0175|cit175","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00006454-199601000-00011","article-title":"Safety and immunogenicity of one vs. two injections of Oka\/Merck varicella vaccine in healthy children","volume":"15","author":"Ngai","year":"1996","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"2","key":"10.1002\/14651858.CD001833.pub3-BIB0176|cit176","first-page":"101","article-title":"Immunogenicity and adverse effects of live attenuated varicella vaccine (Oka-strain) in children with chronic liver disease","volume":"19","author":"Nithichaiyo","year":"2001","journal-title":"Asian Pacific Journal of Allergy & Immunology"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0264-410X(02)00459-0","article-title":"Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine","volume":"21","author":"Nolan","year":"2002","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0178|cit178","first-page":"508","article-title":"Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age","volume":"3","author":"Nolan","journal-title":"Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD001833.pub3-BIB0179|cit179","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1590\/S0034-89102010000200020","article-title":"Anaphylaxis associated with the vaccine against measles, mumps and rubella","volume":"44","author":"Novadzki","year":"2009","journal-title":"Revisita de Sa\u00fade P\u00fablica"},{"issue":"22","key":"10.1002\/14651858.CD001833.pub3-BIB0180|cit180","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001833.pub3-BIB0181|cit181","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1086\/522159","article-title":"Vaccination against herpes zoster and postherpetic neuralgia","volume":"197","author":"Oxman","year":"2008","journal-title":"Journal of Infectious Diseases"},{"issue":"6 Suppl 2","key":"10.1002\/14651858.CD001833.pub3-BIB0182|cit182","first-page":"13","article-title":"Herpes zoster pathogenesis and cell-mediated immunity and immunosenescence","volume":"109","author":"Oxman","year":"2009","journal-title":"Journal of the American Osteopathic Association"},{"issue":"2","key":"10.1002\/14651858.CD001833.pub3-BIB0183|cit183","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1086\/653605","article-title":"Zoster vaccine: current status and future prospects","volume":"51","author":"Oxman","year":"2010","journal-title":"Clinical Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD001833.pub3-BIB0184|cit184","first-page":"69","article-title":"Use of a live varicella vaccine for acute leukemic children shortly after exposure in a children's ward","volume":"21","author":"Ozaki","year":"1978","journal-title":"Biken Journal"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0185|cit185","first-page":"39","article-title":"Clinical trial of the Oka strain of live attenuated varicella vaccine on healthy children","volume":"27","author":"Ozaki","year":"1984","journal-title":"Biken Journal"},{"issue":"10","key":"10.1002\/14651858.CD001833.pub3-BIB0186|cit186","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1080\/00365540310015719","article-title":"Immunogenicity and reactogenicity of a single dose of live attenuated varicella vaccine and a booster dose of measles-mumps-rubella vaccine given concomitantly at 12 years of age","volume":"35","author":"Parment","year":"2003","journal-title":"Scandinavian Journal of Infectious Diseases"},{"issue":"7","key":"10.1002\/14651858.CD001833.pub3-BIB0187|cit187","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/acr.20183","article-title":"Safety and immunogenicity of varicella vaccine in patients with juvenile rheumatic diseases receiving methotrexate and corticosteroids","volume":"62","author":"Pileggi","year":"2010","journal-title":"Arthritis Care and Research"},{"issue":"6","key":"10.1002\/14651858.CD001833.pub3-BIB0188|cit188","doi-asserted-by":"crossref","first-page":"635","DOI":"10.4067\/S0716-10182012000700008","article-title":"Effectiveness of varicella vaccine as post exposure prophylaxis in Chilean children","volume":"29","author":"Pinochet","year":"2012","journal-title":"Revista Chilena de Infectolog\u00eda"},{"issue":"1","key":"10.1002\/14651858.CD001833.pub3-BIB0189|cit189","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1399-3046.2009.01204.x","article-title":"Varicella vaccination in pediatric kidney and liver transplantation","volume":"14","author":"Prelog","year":"2010","journal-title":"Pediatric Transplantation"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0190|cit190","doi-asserted-by":"publisher","first-page":"61461","DOI":"10.1016\/S0140-6736","article-title":"Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine versus one dose of monovalent varicella vaccine: a multicentre, observer-blind, randomised, controlled trial","volume":"12","author":"Prymula","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD001833.pub3-BIB0191|cit191","first-page":"47","article-title":"Varicella outbreak in a village in Uruguay","volume":"27","author":"Quian","year":"2010","journal-title":"Revisita Chilena de Infectologia"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0192|cit192","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0022-3476(97)70094-5","article-title":"Response to the varicella vaccine in children with nephrotic syndrome","volume":"131","author":"Quien","year":"1997","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0193|cit193","first-page":"1295","article-title":"Immunogenicity and safety of a live attenuated varicella vaccine in healthy Indian children aged 9-24 months","volume":"85","author":"Ramkissoon","year":"1995","journal-title":"South African Medical Journal"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0194|cit194","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1086\/514077","article-title":"Early reconstitution of immunity and decreased severity of herpes zoster in bone marrow transplant recipients immunized with inactivated varicella vaccine","volume":"176","author":"Redman","year":"1997","journal-title":"Journal of Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD001833.pub3-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1542\/peds.2005-0092","article-title":"A combination measles, mumps, rubella, and varicella vaccine (ProQuad) given to 4- to 6-year-old healthy children vaccinated previously with M-M-RII and Varivax [Erratum appears in Pediatrics. 2006 Jun;117(6):2338]","volume":"117","author":"Reisinger","year":"2006","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0196|cit196","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/00006454-199707000-00008","article-title":"Safety and immunogenicity of concurrent administration of measles-mumps-rubella-varicella vaccine and PedvaxHIB vaccines in healthy children twelve to eighteen months old. The MMRV Study Group","volume":"16","author":"Reuman","year":"1997","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"2","key":"10.1002\/14651858.CD001833.pub3-BIB0197|cit197","first-page":"88","article-title":"Vaccines against varicella in children and adults for post-exposure prophylaxis","volume":"17","author":"Riera","year":"2012","journal-title":"Revista Diagn\u00f3stico e Tratamento"},{"issue":"10","key":"10.1002\/14651858.CD001833.pub3-BIB0198|cit198","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1097\/INF.0b013e31822256a5","article-title":"Immunogenicity and safety of an inactivated hepatitis A vaccine when coadministered with measles-mumps-rubella and varicella vaccines in children less than 2 years of age","volume":"30","author":"Rinderknecht","year":"2011","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"1","key":"10.1002\/14651858.CD001833.pub3-BIB0199|cit199","first-page":"35","article-title":"Sepsis by S. aureus in a patient with atopic dermatitis and herpeticum eczema: a case report","volume":"32","author":"Rios","year":"2009","journal-title":"Revista Brasileira de Alergia e Imunopatologia"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0200|cit200","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0895-4356(96)00300-9","article-title":"The varicella zoster virus: a pilot trial of a potential therapeutic agent in multiple sclerosis","volume":"50","author":"Ross","year":"1997","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0201|cit201","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/infdis\/175.2.444","article-title":"Dose titration study of live attenuated varicella vaccine in healthy children. Pennridge Pediatric Associates","volume":"175","author":"Rothstein","year":"1997","journal-title":"Journal of Infectious Diseases"},{"issue":"6","key":"10.1002\/14651858.CD001833.pub3-BIB0202|cit202","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1586\/14760584.7.6.753","article-title":"Cost-effectiveness of varicella vaccination programs: an update of the literature","volume":"7","author":"Rozenbaum","year":"2008","journal-title":"Expert Review of Vaccines"},{"issue":"11","key":"10.1002\/14651858.CD001833.pub3-BIB0203|cit203","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1097\/INF.0b013e318267fd8b","article-title":"Safety of a 2-dose regimen of a combined measles, mumps, rubella and varicella live vaccine manufactured with recombinant human albumin","volume":"31","author":"Ruger","year":"2012","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"22","key":"10.1002\/14651858.CD001833.pub3-BIB0204|cit204","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1016\/j.vaccine.2011.02.067","article-title":"Immunogenicity and safety of a measles-mumps-rubella-varicella vaccine following a 4-week or a 12-month interval between two doses","volume":"29","author":"Rumke","year":"2011","journal-title":"Vaccine"},{"issue":"9","key":"10.1002\/14651858.CD001833.pub3-BIB0205|cit205","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1086\/592219","article-title":"Measurement of varicella-zoster virus (VZV)-specific cell-mediated immunity: comparison between VZV skin test and interferon-(gamma) enzyme-linked immunospot assay","volume":"198","author":"Sadaoka","year":"2008","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0206|cit206","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1086\/501900","article-title":"Persistence of immunity to varicella-zoster virus after vaccination of healthcare workers","volume":"22","author":"Saiman","year":"2001","journal-title":"Infection Control & Hospital Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD001833.pub3-BIB0207|cit207","first-page":"5","article-title":"Chapter 7. Chickenpox vaccine for adolescents and adults","volume":"15","author":"Salleras","year":"2009","journal-title":"Medicina Preventiva"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001833.pub3-BIB0208|cit208","first-page":"29","article-title":"Vaccines against varicella-zoster virus","volume":"26","author":"Salleras Sanmarti","year":"2008","journal-title":"Enfermedades Infecciosas y Microbiologia Clinica"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0209|cit209","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/00006454-199803000-00020","article-title":"Postexposure varicella vaccination in siblings of children with active varicella","volume":"17","author":"Salzman","year":"1998","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"2","key":"10.1002\/14651858.CD001833.pub3-BIB0210|cit210","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2165\/10489140-000000000-00000","article-title":"Zoster vaccine (Zostavax): a review of its use in preventing herpes zoster and postherpetic neuralgia in older adults","volume":"27","author":"Sanford","year":"2010","journal-title":"Drugs and Aging"},{"issue":"1","key":"10.1002\/14651858.CD001833.pub3-BIB0211|cit211","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1128\/CMR.00031-09","article-title":"Impact of varicella vaccine on varicella-zoster virus dynamics","volume":"23","author":"Schmid","year":"2010","journal-title":"Clinical Microbiology Reviews"},{"issue":"8","key":"10.1002\/14651858.CD001833.pub3-BIB0212|cit212","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/INF.0b013e318170bb22","article-title":"Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life","volume":"27","author":"Schuster","year":"2008","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001833.pub3-BIB0213|cit213","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1086\/522145","article-title":"Varicella vaccine effectiveness in the US vaccination program: a review","volume":"197","author":"Seward","year":"2008","journal-title":"Journal of Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD001833.pub3-BIB0214|cit214","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/infdis\/jiq052","article-title":"Effectiveness of 2 doses of varicella vaccine in children","volume":"203","author":"Shapiro","year":"2011","journal-title":"Journal of Infectious Disease"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0215|cit215","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1093\/infdis\/165.5.852","article-title":"Kinetics and viral protein specificity of the cytotoxic T lymphocyte response in healthy adults immunized with live attenuated varicella vaccine","volume":"165","author":"Sharp","year":"1992","journal-title":"Journal of Infectious Diseases"},{"issue":"11","key":"10.1002\/14651858.CD001833.pub3-BIB0216|cit216","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/00006454-199811000-00003","article-title":"Safety, tolerability and immunogenicity of concomitant injections in separate locations of M-M-R II, VARIVAX and TETRAMUNE in healthy children vs. concomitant injections of M-M-R II and TETRAMUNE followed six weeks later by VARIVAX","volume":"17","author":"Shinefield","year":"1998","journal-title":"Pediatric Infectious Disease Journal"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0217|cit217","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/00006454-200206000-00014","article-title":"Vaccination with measles, mumps and rubella vaccine and varicella vaccine: safety, tolerability, immunogenicity, persistence of antibody and duration of protection against varicella in healthy children","volume":"21","author":"Shinefield","year":"2002","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"8","key":"10.1002\/14651858.CD001833.pub3-BIB0218|cit218","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/01.inf.0000172902.25009.a1","article-title":"Evaluation of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children","volume":"24","author":"Shinefield","year":"2005","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"8","key":"10.1002\/14651858.CD001833.pub3-BIB0219|cit219","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1097\/01.inf.0000172901.29621.e9","article-title":"Dose-response study of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children [Erratum appears in Pediatr Infect Dis J. 2005 Nov;24(11):983]","volume":"24","author":"Shinefield","year":"2005","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"4","key":"10.1002\/14651858.CD001833.pub3-BIB0220|cit220","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/01.inf.0000207857.10947.1f","article-title":"Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate\/hepatitis B vaccines and combined diphtheria-tetanus-acellular pertussis vaccines","volume":"25","author":"Shinefield","year":"2006","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001833.pub3-BIB0221|cit221","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1086\/522126","article-title":"Varicella immunogenicity with 1- and 2-dose regimens of measles-mumps-rubella-varicella vaccine","volume":"197","author":"Shinefield","year":"2008","journal-title":"Journal of Infectious Diseases"},{"issue":"9","key":"10.1002\/14651858.CD001833.pub3-BIB0222|cit222","doi-asserted-by":"crossref","first-page":"545","DOI":"10.7326\/0003-4819-152-9-201005040-00004","article-title":"Safety of herpes zoster vaccine in the shingles prevention study: a randomized trial","volume":"152","author":"Simberkoff","year":"2010","journal-title":"Annals of Internal Medicine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001833.pub3-BIB0223|cit223","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/jmv.10318","article-title":"Measurement of cell-mediated immunity with a varicella-zoster virus-specific interferon-gamma ELISPOT assay: responses in an elderly population receiving a booster immunization","volume":"70","author":"Smith","year":"2003","journal-title":"Journal of Medical Virology"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0224|cit224","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0166-3542(92)90042-4","article-title":"Serologic response and reactogenicity to booster immunization of healthy seropositive adults with live or inactivated varicella vaccine","volume":"17","author":"Sperber","year":"1992","journal-title":"Antiviral Research"},{"issue":"2","key":"10.1002\/14651858.CD001833.pub3-BIB0225|cit225","doi-asserted-by":"crossref","first-page":"S168","DOI":"10.1016\/j.bbmt.2012.11.140","article-title":"One-year safety and immunogenicity of two formulations of an adjuvanted varicella-zoster virus (VZV) subunit candidate vaccine in adult autologous hematopoietic cell transplant (HCT) recipients","volume":"19","author":"Stadtmauer","year":"2013","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"35","key":"10.1002\/14651858.CD001833.pub3-BIB0226|cit226","doi-asserted-by":"crossref","first-page":"5738","DOI":"10.1016\/j.vaccine.2010.06.007","article-title":"Varicella vaccination coverage in Bavaria (Germany) after general vaccine recommendation in 2004","volume":"28","author":"Streng","year":"2010","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0227|cit227","first-page":"113","article-title":"Concomitant administration of varicella vaccine with combined measles, mumps, and rubella vaccine in healthy children aged 12 to 24 months of age","volume":"20","author":"Stuck","year":"2002","journal-title":"Asian Pacific Journal of Allergy & Immunology"},{"issue":"5","key":"10.1002\/14651858.CD001833.pub3-BIB0228|cit228","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1128\/CVI.00407-08","article-title":"Comparison of the levels of immunogenicity and safety of Zostavax in adults 50 to 59 years old and in adults 60 years old or older","volume":"16","author":"Sutradhar","year":"2009","journal-title":"Clinical and Vaccine Immunology"},{"issue":"7892","key":"10.1002\/14651858.CD001833.pub3-BIB0229|cit229","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0140-6736(74)90144-5","article-title":"Live vaccine used to prevent the spread of varicella in children in hospital","volume":"2","author":"Takahashi","year":"1974","journal-title":"Lancet"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD001833.pub3-BIB0230|cit230","first-page":"61","article-title":"Clinical experience with Oka live varicella vaccine in Japan","volume":"61","author":"Takahashi","year":"1985","journal-title":"Postgraduate Medical Journal"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0231|cit231","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2165\/00128072-200103040-00005","article-title":"25 years' experience with the Biken Oka strain varicella vaccine: a clinical overview","volume":"3","author":"Takahashi","year":"2001","journal-title":"Paediatric Drugs"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0232|cit232","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1016\/S0264-410X(03)00303-7","article-title":"Enhancement of immunity against VZV by giving live varicella vaccine to the elderly assessed by VZV skin test and IAHA, gpELISA antibody assay","volume":"21","author":"Takahashi","year":"2003","journal-title":"Vaccine"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001833.pub3-BIB0233|cit233","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1086\/522132","article-title":"Development of varicella vaccine","volume":"197","author":"Takahashi","year":"2008","journal-title":"Journal of Infectious Diseases"},{"issue":"6","key":"10.1002\/14651858.CD001833.pub3-BIB0234|cit234","doi-asserted-by":"crossref","first-page":"776","DOI":"10.11150\/kansenshogakuzasshi1970.66.776","article-title":"Immunization of healthy children with measles-mumps-rubella trivalent vaccine simultaneously given with varicella vaccine","volume":"66","author":"Takayama","year":"1992","journal-title":"Kansenshogaku Zasshi [Journal of the Japanese Association for Infectious Diseases]"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0235|cit235","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1007\/BF01957158","article-title":"Use of a reformulated Oka strain varicella vaccine (SmithKline Beecham Biologicals\/Oka) in healthy children","volume":"155","author":"Tan","year":"1996","journal-title":"European Journal of Pediatrics"},{"issue":"11","key":"10.1002\/14651858.CD001833.pub3-BIB0236|cit236","first-page":"1516","article-title":"Safety and immunogenicity of domestic gelatin-free freeze-dried live attenuated varicella vaccine","volume":"25","author":"Tang","year":"2012","journal-title":"Chinese Journal of Biologicals"},{"issue":"31-2","key":"10.1002\/14651858.CD001833.pub3-BIB0237|cit237","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1016\/S0264-410X(02)00408-5","article-title":"Responses of varicella zoster virus (VZV)-specific immunity in seropositive adults after inhalation of inactivated or live attenuated varicella vaccine","volume":"20","author":"Terada","year":"2002","journal-title":"Vaccine"},{"issue":"22","key":"10.1002\/14651858.CD001833.pub3-BIB0238|cit238","doi-asserted-by":"crossref","first-page":"11023","DOI":"10.1128\/JVI.00777-08","article-title":"Complete DNA sequences of two Oka strain varicella-zoster virus genomes","volume":"82","author":"Tillieux","year":"2008","journal-title":"Journal of Virology"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0239|cit239","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/S0264-410X(99)00510-1","article-title":"Vaccination of immunocompetent elderly subjects with a live attenuate Oka strain of varicella zoster virus: a randomized, controlled, dose-response trial","volume":"18","author":"Trannoy","year":"2000","journal-title":"Vaccine"},{"issue":"3-4","key":"10.1002\/14651858.CD001833.pub3-BIB0240|cit240","first-page":"117","article-title":"Use of a live varicella vaccine to prevent the spread of varicella in handicapped or immunosuppressed children including MCLS (muco-cutaneous lymphnode syndrome) patients in hospitals","volume":"20","author":"Ueda","year":"1977","journal-title":"Biken Journal"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD001833.pub3-BIB0241|cit241","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/infdis\/174.Supplement_3.S330","article-title":"Efficacy of high-titer live attenuated varicella vaccine in healthy young children","volume":"174","author":"Varis","year":"1996","journal-title":"Journal of Infectious Diseases"},{"issue":"7","key":"10.1002\/14651858.CD001833.pub3-BIB0242|cit242","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jama.291.7.851","article-title":"Effectiveness over time of varicella vaccine","volume":"291","author":"Vazquez","year":"2004","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0243|cit243","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1651-2227.1991.tb11782.x","article-title":"Evaluation of live attenuated varicella vaccine (Oka-RIT strain) and combined varicella and MMR vaccination in 13-17-month-old children","volume":"80","author":"Vesikari","year":"1991","journal-title":"Acta Paediatrica Scandinavica"},{"issue":"2","key":"10.1002\/14651858.CD001833.pub3-BIB0244|cit244","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/01.inf.0000250689.09396.21","article-title":"Immunogenicity and safety of a second dose of measles-mumps-rubella- varicella vaccine in healthy children aged 5 to 6 years","volume":"26","author":"Vesikari","year":"2007","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"6","key":"10.1002\/14651858.CD001833.pub3-BIB0245|cit245","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1097\/INF.0b013e3181dffabf","article-title":"Safety and immunogenicity of a booster dose of the 10-valent pneumococcal nontypeable haemophilus influenzae protein D conjugate vaccine coadministered with measles-mumps-rubella-varicella vaccine in children aged 12 to 16 months","volume":"29","author":"Vesikari","year":"2010","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"20","key":"10.1002\/14651858.CD001833.pub3-BIB0246|cit246","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1016\/j.vaccine.2012.02.062","article-title":"Immunogenicity and safety of a two-dose regimen of a combined measles, mumps, rubella and varicella live vaccine (ProQuad(\u00ae)) in infants from 9 months of age","volume":"30","author":"Vesikari","year":"2012","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0247|cit247","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1067\/mpd.2001.116051","article-title":"Childhood vaccination against varicella: persistence of antibody, duration of protection, and vaccine efficacy","volume":"139","author":"Vessey","year":"2001","journal-title":"Journal of Pediatrics"},{"issue":"37","key":"10.1002\/14651858.CD001833.pub3-BIB0248|cit248","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1016\/j.vaccine.2013.06.075","article-title":"Single-dose varicella vaccine effectiveness in school settings in China","volume":"31","author":"Wang","year":"2013","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0249|cit249","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1093\/infdis\/168.6.1356","article-title":"The effect of decreasing amounts of live virus, while antigen content remains constant, on immunogenicity of Oka\/Merck varicella vaccine","volume":"168","author":"Watson","year":"1993","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0250|cit250","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1542\/peds.91.1.17","article-title":"Modified chickenpox in children immunized with the Oka\/Merck varicella vaccine","volume":"91","author":"Watson","year":"1993","journal-title":"Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD001833.pub3-BIB0251|cit251","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/infdis\/169.1.197","article-title":"Persistence of cell-mediated and humoral immune responses in healthy children immunized with live attenuated varicella vaccine","volume":"169","author":"Watson","year":"1994","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0252|cit252","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/clinids\/20.2.316","article-title":"Humoral and cell-mediated immune responses in healthy children after one or two doses of varicella vaccine","volume":"20","author":"Watson","year":"1995","journal-title":"Clinical Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD001833.pub3-BIB0253|cit253","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/infdis\/173.3.731","article-title":"Safety and immunogenicity of a combined live attenuated measles, mumps, rubella, and varicella vaccine (MMR(II)V) in healthy children [Erratum appears in J Infect Dis 1996 Jun;173(6):1529]","volume":"173","author":"Watson","year":"1996","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0254|cit254","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1542\/peds.105.1.84","article-title":"Postexposure effectiveness of varicella vaccine","volume":"105","author":"Watson","year":"2000","journal-title":"Pediatrics"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001833.pub3-BIB0255|cit255","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1086\/522130","article-title":"Humoral and cell-mediated immune responses in children and adults after 1 and 2 doses of varicella vaccine","volume":"197","author":"Watson","year":"2008","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0256|cit256","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/adc.82.2.141","article-title":"Immunisation against varicella in end stage and pre-end stage renal failure. Trans-Pennine Paediatric Nephrology Study Group","volume":"82","author":"Webb","year":"2000","journal-title":"Archives of Disease in Childhood"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0257|cit257","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1056\/NEJM198405313102201","article-title":"Live attenuated varicella virus vaccine. Efficacy trial in healthy children","volume":"310","author":"Weibel","year":"1984","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0258|cit258","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1001\/jama.1985.03360170075034","article-title":"Live Oka\/Merck varicella vaccine in healthy children. Further clinical and laboratory assessment","volume":"254","author":"Weibel","year":"1985","journal-title":"JAMA"},{"issue":"7","key":"10.1002\/14651858.CD001833.pub3-BIB0259|cit259","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1086\/605611","article-title":"Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine","volume":"200","author":"Weinberg","year":"2009","journal-title":"Journal of Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD001833.pub3-BIB0260|cit260","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4161\/hv.6.4.10654","article-title":"Safety and immunogenicity of a live attenuated varicella vaccine in VZV-seropositive HIV-infected adults","volume":"6","author":"Weinberg","year":"2010","journal-title":"Human Vaccines"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0261|cit261","first-page":"604","article-title":"Varicella vaccine (VARIVAX) in healthy children and adolescents: results from clinical trials, 1987 to 1989","volume":"87","author":"White","year":"1991","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0262|cit262","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00006454-199201000-00006","article-title":"Modified cases of chickenpox after varicella vaccination: correlation of protection with antibody response","volume":"11","author":"White","year":"1992","journal-title":"Pediatric Infectious Disease Journal"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0263|cit263","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/clinids\/24.5.753","article-title":"Varicella-zoster virus vaccine","volume":"24","author":"White","year":"1997","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0264|cit264","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1001\/jama.284.10.1271","article-title":"Postlicensure safety surveillance for varicella vaccine [Erratum appears in JAMA 2000 Dec 27;284(24):3129]","volume":"284","author":"Wise","year":"2000","journal-title":"JAMA"},{"issue":"7","key":"10.1002\/14651858.CD001833.pub3-BIB0265|cit265","first-page":"862","article-title":"Immunogenicity and safety of measles-mumps-rubella-varicella vaccine: a systematic review","volume":"10","author":"Wu","year":"2010","journal-title":"Chinese Journal of Evidence-Based Medicine"},{"issue":"1","key":"10.1002\/14651858.CD001833.pub3-BIB0266|cit266","first-page":"3","article-title":"Knowledge about varicella by first year healthcare students in State University of Londrina and verification of the presence of varicella scars in the students","volume":"29","author":"Yamaguti","year":"2008","journal-title":"Semina: Ci\u00eancias Biol\u00f3gicas e da Sa\u00fade, Londrina"},{"issue":"10","key":"10.1002\/14651858.CD001833.pub3-BIB0267|cit267","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.vaccine.2006.11.022","article-title":"Assessment of the potency and potential immunomodulatory effects of the measles mumps rubella and varicella vaccine in infants","volume":"25","author":"Yerkovich","year":"2007","journal-title":"Vaccine"},{"issue":"8","key":"10.1002\/14651858.CD001833.pub3-BIB0268|cit268","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.4161\/hv.24873","article-title":"Concomitant administration of hepatitis A vaccine with measles\/mumps\/rubella\/varicella and pneumococcal vaccines in healthy 12- to 23-month-old children","volume":"9","author":"Yetman","year":"2013","journal-title":"Human Vaccines and Immunotherapeutics"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0269|cit269","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/08880019209006393","article-title":"Varicella vaccine in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma","volume":"9","author":"Yeung","year":"1992","journal-title":"Pediatric Hematology & Oncology"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0270|cit270","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1086\/517426","article-title":"Analysis of the persistence of humoral and cellular immunity in children and adults immunized with varicella vaccine","volume":"177","author":"Zerboni","year":"1998","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0271|cit271","volume-title":"The Australian Immunisation Handbook","author":"Australian Technical Advisory Group on Immunisation (ATAGI)","year":"2013"},{"issue":"12","key":"10.1002\/14651858.CD001833.pub3-BIB0272|cit272","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1097\/00006454-199912000-00003","article-title":"Postmarketing evaluation of the safety and effectiveness of varicella vaccine","volume":"18","author":"Black","year":"1999","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"10","key":"10.1002\/14651858.CD001833.pub3-BIB0273|cit273","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1136\/jcp.54.10.743","article-title":"Vaccination to prevent varicella and shingles","volume":"54","author":"Breuer","year":"2001","journal-title":"Journal of Clinical Pathology"},{"issue":"8912","key":"10.1002\/14651858.CD001833.pub3-BIB0274|cit274","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/S0140-6736(94)92943-2","article-title":"Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases","volume":"343","author":"Enders","year":"1994","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0275|cit275","first-page":"13","article-title":"Varicella vaccine in post-exposure prophylaxis","volume":"25","author":"Ferson","year":"2001","journal-title":"Communicable Diseases Intelligence"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0276|cit276","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/B978-1-4557-0090-5.00042-2","article-title":"Varicella vaccine","volume-title":"Vaccines","author":"Gershon","year":"2013"},{"issue":"5","key":"10.1002\/14651858.CD001833.pub3-BIB0277|cit277","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJMcp013211","article-title":"Clinical practice. Herpes zoster","volume":"347","author":"Gnann","year":"2002","journal-title":"New England Journal of Medicine"},{"issue":"4 Pt 2","key":"10.1002\/14651858.CD001833.pub3-BIB0278|cit278","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1542\/peds.78.4.723","article-title":"Population-based studies of varicella complications","volume":"78","author":"Guess","year":"1986","journal-title":"Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD001833.pub3-BIB0279|cit279","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1128\/CMR.18.1.70-80.2005","article-title":"Preventing varicella-zoster disease","volume":"18","author":"Hambleton","year":"2005","journal-title":"Clinical Microbiology Reviews"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0280|cit280","article-title":"Chapter 8: Assessing risk of bias in included studies","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2011"},{"issue":"3","key":"10.1002\/14651858.CD001833.pub3-BIB0281|cit281","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1440-1754.1996.tb01556.x","article-title":"Acyclovir for the prevention and treatment of varicella zoster in children, adolescents and pregnancy","volume":"32","author":"Kesson","year":"1996","journal-title":"Journal of Paediatrics and Child Health"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0282|cit282","article-title":"Chapter 6: Searching for studies","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Lefebvre","year":"2011"},{"issue":"11","key":"10.1002\/14651858.CD001833.pub3-BIB0283|cit283","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1440-1754.2005.00717.x","article-title":"Varicella vaccination in Australia","volume":"41","author":"Macartney","year":"2005","journal-title":"Journal of Paediatrics and Child Health"},{"issue":"RR-4","key":"10.1002\/14651858.CD001833.pub3-BIB0284|cit284","first-page":"1","article-title":"Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Marin","year":"2007","journal-title":"Morbidity and Mortality Weekly Report"},{"issue":"RR-11","key":"10.1002\/14651858.CD001833.pub3-BIB0285|cit285","first-page":"1","article-title":"Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"45","author":"MMWR","year":"1996","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0286|cit286","first-page":"1","article-title":"National Advisory Committee on Immunization (NACI) update on varicella","volume":"30","author":"National Advisory Committee on Immunization (NACI)","year":"2004","journal-title":"Canada Communicable Disease Report"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001833.pub3-BIB0287|cit287","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0163-4453(98)80153-9","article-title":"Antiviral prophylaxis and treatment in chickenpox. A review prepared for the UK Advisory Group on Chickenpox on behalf of the British Society for the Study of Infection","volume":"36","author":"Ogilvie","year":"1998","journal-title":"Journal of Infection"},{"issue":"13","key":"10.1002\/14651858.CD001833.pub3-BIB0288|cit288","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJM199403313301305","article-title":"Outcome after maternal varicella infection in the first 20 weeks of pregnancy","volume":"330","author":"Pastuszac","year":"1994","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD001833.pub3-BIB0289|cit289","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/00006454-198411000-00004","article-title":"Varicella: clinical manifestations, epidemiology and health impact in children","volume":"3","author":"Preblud","year":"1984","journal-title":"Pediatric Infectious Disease Journal"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0290|cit290","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/adc.2007.126243","article-title":"Impact of universal varicella vaccination on 1-year olds in Uruguay: 1997\u20132005","volume":"93","author":"Quian","year":"2008","journal-title":"Archives of Disease in Childhood"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0291|cit291","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2012"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001833.pub3-BIB0292|cit292","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1086\/522163","article-title":"Varicella vaccination in Japan, South Korea, and Europe","volume":"197","author":"Sadzot-Delvaux","year":"2008","journal-title":"Journal of Infectious Diseases"},{"issue":"7-8","key":"10.1002\/14651858.CD001833.pub3-BIB0293|cit293","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S0264-410X(00)00297-8","article-title":"The postmarketing safety profile of varicella vaccine","volume":"19","author":"Sharrar","year":"2000","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD001833.pub3-BIB0294|cit294","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0140-6736(52)91357-3","article-title":"Infectiousness of communicable diseases in the household (measles, chickenpox, and mumps)","volume":"ii","author":"Simpson","year":"1952","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD001833.pub3-BIB0295|cit295","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/adc.85.2.83","article-title":"Varicella vaccination - a critical review of the evidence","volume":"85","author":"Skull","year":"2001","journal-title":"Archives of Disease in Childhood"},{"issue":"3","key":"10.1002\/14651858.CD001833.pub3-BIB0296|cit296","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0891-5520(05)70309-3","article-title":"The varicella vaccine. Vaccine development","volume":"10","author":"Takahashi","year":"1996","journal-title":"Infectious Disease Clinics of North America"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD001833.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T18:38:57Z","timestamp":1720982337000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD001833.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Acute Respiratory Infections Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,6,23]]},"references-count":296,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001833.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,23]]}}}